C-reactive protein in the diagnosis of melioidosis

American Journal of Tropical Medicine and Hygiene

Volumn 70, Issue 5, 2004, Pages 580-582

  Cheng, Allen C ^a   O'Brien, Matthew ^b   Jacups, Susan P ^a   Anstey, Nicholas M ^a   Currie, Bart J ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CEFTAZIDIME; COTRIMOXAZOLE; MEROPENEM;

ACUTE DISEASE; ARTICLE; BLOOD CULTURE; BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; CHRONIC DISEASE; CHRONIC LUNG DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DIAGNOSTIC TEST; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MELIOIDOSIS; MORTALITY; RELAPSE; SEPSIS; SEROLOGY;

BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; NEGIBACTERIA;

EID: 2442696511     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2004.70.580     Document Type: Article

References (14)

1. White NJ, 2003. Melioidosis. Lancet 361: 1715-1722.
2. Reny J, Vuagnat A, Ract C, Benoit M, Safar M, Fagon J, 2002. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 30: 529-535.
3. Povoa P, 2002. C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28: 235-243.
4. van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, Limburg PC, 1994. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 21: 425-429.
5. Ashdown LR, 1992. Serial serum C-reactive protein levels as an aid to the management of melioidosis. Am J Trop Med Hyg 46: 151-157.
6. Currie BJ, Fisher DA, Howard DM, Burrow JN, Lo D, Selva-Nayagam S, Anstey NM, Huffam SE, Snelling PL, Marks PJ, Stephens DP, Lum GD, Jacups SP, Krause VL, 2000. Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 31: 981-986.
7. ACCP/SCCM, 1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874.
8. Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ, 2003. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 53: 358-364.
9. Smith MD, Suputtamongkol Y, Chaowagul W, Assicot M, Bohuon C, Petitjean S, White NJ, 1995. Elevated serum procalcitonin levels in patients with melioidosis. Clin Infect Dis 20: 641-645.
10. Prat C, Dominguez J, Rodrigo C, Gimenez M, Azuara M, Jimenez O, Gali N, Ausina V, Resch B, Gusenleitner W, Muller WD, Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A, 2003. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J 22: 963-968.
11. Resch B, Gusenleitner W, Muller WD, Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A, 2003. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 92: 243-245.
12. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A, 2003. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med 31: 1737-1741.
13. Friedland JS, Suputtamongkol Y, Remick DG, Chaowagul W, Strieter RM, Kunkel SL, White NJ, Griffin GE, 1992. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 60: 2402-2408.
14. Simpson AJ, Smith MD, Weverling GJ, Suputtamongkol Y, Angus BJ, Chaowagul W, White NJ, van Deventer SJ, Prins JM, 2000. Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis. J Infect Dis 181: 621-625.